Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2025 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences Ltd has informed BSE that its Board of Directors will meet on Thursday, 24 July 2025. The main agenda item is to consider and approve the unaudited financial results for the first quarter ending 30 June 2025. Any other business items may also be discussed with the Board's permission. This is a routine regulatory disclosure under SEBI's Listing Regulations, and no financial numbers have been shared yet in this filing.
This is a standard procedural announcement with no immediate impact on the stock. Investors should watch for the actual Q1 results, which are expected to be released on or shortly after 24 July 2025, for any insights into the company's quarterly performance.